Evolution of overall survival (OS) after curative-intent lung cancer surgery in a population-based Mississippi Delta cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium.
The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT). Baseline characteristics of parents enrolled in ACCL20N1CD: Financial distress during treatment for pediatric acute ...
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
The March 20, 2024, article by Berman et al entitled “CML and the WHO: Why?” (J Clin Oncol 10.1200/JCO.23.01689) was published with an error. In the author list ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback